Cynapsus Therapeutics

Cynapsus Therapeutics

Cynapsus Therapeutics is a pharmaceutical subsidiary of Sunovion developing a non-injectable rescue therapy for Parkinson’s disease symptoms. The company was founded in 2004 and is headquartered in Toronto, Ontario, Canada.

All edits

Edits on 12 Aug, 2020
Lax Mariappan
Lax Mariappan edited on 12 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Founded date
2004
Edits on 1 Aug, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 1 Aug, 2020
Edits made to:
Infobox (+1/-1 properties)
Infobox
Total funding amount (USD)
36,801,500
Total funding amount (USD)
37,301,500
Golden AI
Golden AI edited on 1 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Cynapsus Therapeutics Grant July 2014
Golden AI"Funding autocalculation"
Golden AI edited on 1 Aug, 2020
Edits made to:
Infobox (+1/-1 properties)
Infobox
Total funding amount (USD)
19,539,500
Total funding amount (USD)
36,801,500
Golden AI
Golden AI edited on 1 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Cynapsus Therapeutics Venture Funding Round March 2015
Golden AI"Funding autocalculation"
Golden AI edited on 1 Aug, 2020
Edits made to:
Infobox (+1/-1 properties)
Infobox
Total funding amount (USD)
5,039,500
Total funding amount (USD)
19,539,500
Golden AI
Golden AI edited on 1 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Cynapsus Therapeutics Venture Funding Round April 2014
Golden AI"Funding autocalculation"
Golden AI edited on 1 Aug, 2020
Edits made to:
Infobox (+1/-1 properties)
Infobox
Total funding amount (USD)
4,100,000
Total funding amount (USD)
5,039,500
Golden AI
Golden AI edited on 1 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Cynapsus Therapeutics Venture Funding Round March 2012
Golden AI"Funding autocalculation"
Golden AI edited on 1 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Total funding amount (USD)
4,100,000
Golden AI
Golden AI edited on 1 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Cynapsus Therapeutics Venture Funding Round March 2013
Marie Gabrielle Laguna- Bedia
Marie Gabrielle Laguna- Bedia edited on 1 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
CEO
Anthony Giovinazzo
Edits on 30 Jul, 2020
Lax Mariappan
Lax Mariappan edited on 30 Jul, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Founder
Andrew Williams
Edits on 23 May, 2020
Golden AI"Wikidata import from WikidataImport2"
Golden AI edited on 23 May, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Wikidata entity ID
Q5199886
Edits on 23 May, 2019
Golden AI
Golden AI edited on 23 May, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Location
Toronto
Edits on 2 Apr, 2019
Dawson Sewell
Dawson Sewell edited on 2 Apr, 2019
Edits made to:
Infobox (+3 properties)
Article (+358/-282 characters)
Categories (-1 topics)
Related Topics (+1 topics)
Article

Cynapsus Therapeutics is a specialty pharmaceutical company developing oral drug treatments for Parkinson's disease. Cynapsus Therapeutics was founded in 20041984 by Anthony Giovinazzo and is headquartered in Toronto, Ontario, Canada. On September 1, 2016 Sunovion Pharmaceuticals acquired Cynapsus Therapeutics to expand its own drug portfolio to treat diseases on the central nervous system. Sunovion Pharmaceuticals purchased Cynapsus Therapeutics for approximately $624 million at $40.50 per share in cash.

Products

APL-130277

...

Acquired by Sunovion Pharmaceuticals

On September 1, 2016 Sunovion Pharmaceuticals acquired Cynapsus Therapeutics to expand its own drug portfolio to treat diseases on the central nervous system. Sunovion Pharmaceuticals purchased Cynapsus Therapeutics for approximately $624 million at $40.50 per share in cash.

Infobox
Industry
Therapeutics
Date incorporated
2004
Categories
Related Topics
Edits on 4 Feb, 2019
Golden AI"Import data"
Golden AI edited on 4 Feb, 2019
Edits made to:
Infobox (+1 properties)
People (+2 rows) (+4 cells) (+45 characters)
People

Name
Role
Related Golden topics

David J. Duff

Employee

Dawson Sprigings

Employee

Infobox
Industry
Biotechnology
Edits on 16 Jan, 2019
Golden AI"Import data"
Golden AI edited on 16 Jan, 2019
Edits made to:
Infobox (+2 properties)
Infobox
Market
Biotechnology
Edits on 10 Jan, 2019
Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 10 Jan, 2019
Edits made to:
Article (+6/-6 characters)
Article

Cynapsus Therapeutics is a specialty pharmaceutical company developing oral drug treatments for Parkinson's disease. Cynapsus Therapeutics was founded in 2004 and is headquartered in Toronto, Ontario, CanadaCanada. On September 1, 2016 Sunovion Pharmaceuticals acquired Cynapsus Therapeutics to expand its own drug portfolio to treat diseases on the central nervous system. Sunovion Pharmaceuticals purchased Cynapsus Therapeutics for approximately $624 million at $40.50 per share in cash.

Edits on 9 Jan, 2019
Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 9 Jan, 2019
Edits made to:
Article (+7/-7 characters)
Article

Cynapsus Therapeutics is a specialty pharmaceutical company developing oral drug treatments for Parkinson's disease. Cynapsus Therapeutics was founded in 2004 and is headquartered in TorontoToronto, Ontario, Canada. On September 1, 2016 Sunovion Pharmaceuticals acquired Cynapsus Therapeutics to expand its own drug portfolio to treat diseases on the central nervous system. Sunovion Pharmaceuticals purchased Cynapsus Therapeutics for approximately $624 million at $40.50 per share in cash.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.